Sign in
4

Changes in Ownership

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-22-004765

Options or other derivatives

  • VP, Chief Commercial Officer acquired 275,560 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Seth Kiernan · VP, Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-02-10 Grant or award : show line 1 in the form Stock Option (Right to Buy) +206,670 206,670 D
2022-02-10 Grant or award : show line 2 in the form Restricted Stock Units +68,890 68,890 D
Loading xslF345X03/form4.xml…